Taiwan beat Vietnam 1-0 in Women's Asian Cup, advancing with three points.

Stanley Druckenmiller sold most of his Teva and TSM shares, bought $301M in financial ETF, signaling shift to financial sector bets.

A Taiwan biotech firm, GNTbm, gained U.S. FDA approval to test its new oral cancer drug, GNTbm-38, in Phase I trials for resistant lymphoma.

Taiwan's stock exchange chief visited the U.S. to strengthen ties with global investors and boost Taiwan’s role as an Asian asset hub.